Navigation Links


RXi Pharmaceuticals to Present an Update on its Consumer Product Development Programs at the Society for Investigative Dermatology 76th Annual Meeting

4/20/2017
MARLBOROUGH, Mass. , April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present new data from the Company's consumer product development program, based on its proprietary self-delivering RNAi (sd-rxRNA®) technology, at the... [Comments]

Global $20 Billion Drug Delivery Technologies Market 2016-2020 - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics - Research and Markets

4/20/2017
DUBLIN , April 20, 2017 Research and Markets has announced the addition of the "Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period" report to their offering. The global market for drug delivery technologies will rise from USD 20 Billion in 2015 t... [Comments]

CVS Pharmacy Unveils Enhanced Customer Experience, New Store Design

4/20/2017
WOONSOCKET, R.I. , April 20, 2017  CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), today unveiled a new store design to enhance the retail customer experience with a new assortment of healthier food, health-focused products and expanded beauty selections paired with informational signage throughout the store to help customers discover new offerings. Together w... [Comments]

ZappRx raises $25 million in Series B funding led by Qiming US Healthcare Fund with Participation from SR One and GV

4/20/2017
BOSTON , April 20, 2017   ZappRx, Inc ., a digital health company focused on modernizing and expediting the specialty drug prescribing process, today announced it closed $25 million in Series B funding led by Qiming US Healthcare Fund, a venture capital firm based in Seattle that is part of a broader family of Qiming Venture Partners . The Series B round included part... [Comments]

AbbVie's Investigational, Pan-Genotypic, Ribavirin-free Regimen of Glecaprevir/Pibrentasvir (G/P) Achieved 99 Percent SVR(12) Rate in Chronic Hepatitis C Patients with Compensated Cirrhosis

4/20/2017
AMSTERDAM , April 20, 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that 99 percent (n=145/146) of chronic hepatitis C virus (HCV) infected patients with genotype 1, 2, 4, 5 or 6 and compensated cirrhosis (Child-Pugh A) achieved sustained virologic response at 12 weeks post-treatment (SVR 12 ) with its investigational, pan-genotypic regimen... [Comments]

Global $11.93 Billion Pharmacogenomics Market 2014-2017 & 2024 - Research and Markets

4/20/2017
DUBLIN , April 20, 2017 Research and Markets has announced the addition of the "Global Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 to 2024" report to their offering. The global pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, and is ex... [Comments]

Eyevensys Receives Approval From the UK Medicines and Healthcare Products Regulatory Agency to Advance its EyeCET Platform Into Clinical Development

4/20/2017
PARIS , April 20, 2017 Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables the safe, local, sustained production of therapeutic proteins in the eye to address a wide range of ophthalmic diseases, announces it has received approval from the UK Medicines and Healthcare products Regul... [Comments]

NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects

4/20/2017
LUND, Sweden , April 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical results demonstrating anti-fibrotic effects with NV556, the company's preclinical compound for non-alcoholic steatohepatitis (NASH), in an additional well-validated experimental NASH model. NV556 has previously shown simila... [Comments]

Latin America Pharmaceutical Contract Manufacturing Services Market 2014-2017 and 2025 - Research and Markets

4/20/2017
DUBLIN , April 20, 2017 Research and Markets has announced the addition of the "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, Chile, Venezuela), And Segment Forecasts, 2014 - 2025" report to their offering. The Latin American pharmaceutica... [Comments]

CRH Medical Corporation To Present at the Bloom Burton & Co. Healthcare Investor Conference

4/19/2017
VANCOUVER , April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate in the Bloom Burton & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in Toronto, Ontario . Edward Wright , Chief Executive Officer of the Company is scheduled to present on Tuesday, May 2 at 10:00 am. The Company's... [Comments]

[previous] [next]
(Date:4/28/2017)... Washington, DC (PRWEB) , ... April 28, 2017 ... ... Unplanned Pregnancy (The National Campaign) announces its support for the Access to ... by Sen. Jeanne Shaheen (D-NH) and Rep. Jackie Speier (D-CA), will help to ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create and edit ... the reporting process and provides a familiar interface that does not require additional ...
(Date:4/28/2017)... ... April 28, 2017 , ... Getting enough sleep affects much more than energy – ... just 19 hours without sleep can compromise motor reaction time, which can increase the risk ... Insurance is sharing the following tips from the NSF to help you sleep better and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly introduces the ... instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ... hour rated lamps utilize the existing electronic ballast, saving labor and maintenance costs. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children ... to more adverse experiences than children in the general population. That’s because foster ... neglect or other family challenges. While no fault of their own, youth who ...
Breaking Medicine News(10 mins):
... 6-inch Electro-Dermatome. This is the only powered ... inch graft can cover most adult hands ... This dermatome has been designed to run ... decreased considerably and the handle temperature is ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
BD Visitec IOL Manipulator, blunt tip, formed 10.0mm from end. Fits 0.20mm diameter holes & larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge indicating positio...
BD Visitec IOL Manipulator (Lester), 0.25 mm diameter tip angled 45 in, 10 mm from end (3/bx, 1 bx/ca), sterile. For positioning intraocular lenses. Sure grip handles hand ridge indicating position o...
Medicine Products:
(Date:4/26/2017)... , April 26, 2017 Phoenix Marketing Solutions ... fifteenth year of fulfilling its mission of transforming science into ... highly scrutinized, Phoenix,s innovative approach supports ... community about the latest advances in science and medicine — ... was founded in 2002 by Tracy Doyle ...
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)...  Vivify Health, the pioneer and market leader of ... very significant patent for the advancement of healthcare delivery ... digital health.  This landmark patent provides the company with ... Vivify,s position as the leader in remote care.  ... company to apply consumer mobile devices, wireless biometrics, EMR ...
Breaking Medicine Technology: